Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.
Journal
NPJ vaccines
ISSN: 2059-0105
Titre abrégé: NPJ Vaccines
Pays: England
ID NLM: 101699863
Informations de publication
Date de publication:
07 Nov 2022
07 Nov 2022
Historique:
received:
31
05
2022
accepted:
10
10
2022
entrez:
7
11
2022
pubmed:
8
11
2022
medline:
8
11
2022
Statut:
epublish
Résumé
Early trials of novel vaccines against tuberculosis (TB) in adults have suggested substantial protection against TB. However, little is known about the feasibility and affordability of rolling out such vaccines in practice. We conducted expert interviews to identify plausible vaccination implementation strategies for the novel M72/AS01
Identifiants
pubmed: 36344523
doi: 10.1038/s41541-022-00554-1
pii: 10.1038/s41541-022-00554-1
pmc: PMC9640704
doi:
Types de publication
Journal Article
Langues
eng
Pagination
138Informations de copyright
© 2022. The Author(s).
Références
BMJ. 2014 Aug 05;349:g4643
pubmed: 25097193
Sci Transl Med. 2020 Oct 7;12(564):
pubmed: 33028708
N Engl J Med. 1992 Jan 23;326(4):231-5
pubmed: 1345800
J Theor Biol. 2019 May 21;469:1-11
pubmed: 30851550
Value Health. 2016 Dec;19(8):921-928
pubmed: 27987641
Clin Infect Dis. 2014 Feb;58(4):470-80
pubmed: 24336911
N Engl J Med. 2018 Jul 12;379(2):138-149
pubmed: 29996082
BMC Med. 2021 Feb 26;19(1):60
pubmed: 33632218
Lancet. 2012 Dec 15;380(9859):2063-6
pubmed: 23245602
Lancet. 1994 Apr 23;343(8904):1021-3
pubmed: 7909054
Arch Intern Med. 2003 May 12;163(9):1009-21
pubmed: 12742798
Clin Microbiol Infect. 2004 May;10(5):388-98
pubmed: 15113314
BMJ Glob Health. 2018 Nov 5;3(6):e000964
pubmed: 30483412
Int J Infect Dis. 2021 Dec;113 Suppl 1:S16-S21
pubmed: 33757874
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15520-5
pubmed: 25288770
Lancet. 2012 Dec 15;380(9859):2129-43
pubmed: 23245605
Medicine (Baltimore). 2018 Nov;97(45):e13120
pubmed: 30407329
Expert Rev Vaccines. 2021 Aug;20(8):921-933
pubmed: 34252336
Am Rev Respir Dis. 1992 Oct;146(4):849-54
pubmed: 1416409
AIDS. 2001 Jan 26;15(2):143-52
pubmed: 11216921
Expert Rev Vaccines. 2022 Apr;21(4):549-559
pubmed: 34990311
J Intern Med. 2020 Dec;288(6):661-681
pubmed: 33128834
Nat Commun. 2022 Feb 1;13(1):602
pubmed: 35105879
N Engl J Med. 2019 Dec 19;381(25):2429-2439
pubmed: 31661198
AIDS. 2014 Jul 31;28(12):1769-81
pubmed: 24911353
Lancet Glob Health. 2019 Feb;7(2):e209-e218
pubmed: 30630775
Health Technol Assess. 2013 Sep;17(37):1-372, v-vi
pubmed: 24021245